Evox Therapeutics

DTX Pharma

This biotechnology firm develops RNA-based therapeutics for patients with rare neuromuscular and central nervous system disorders using a proprietary fatty acid delivery platform.

Exostemtech

This biotechnology firm develops exosome-based therapeutics and production platforms for clinical researchers and healthcare providers treating intractable diseases.

Aegle Therapeutics

This company develops extracellular vesicle therapies derived from stem cells to treat patients with rare dermatological disorders and severe burns.

Quince Therapeutics (formerly EryDel)

This biotechnology company develops red blood cell-based drug delivery systems for patients with rare neurodegenerative diseases such as ataxia-telangiectasia.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

EdiTy Therapeutics

This company develops immune cell delivery platforms to transport therapeutic proteins into diseased cells for patients with cancer and genetic disorders.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

Minoryx

This biotechnology company develops orphan drugs and therapies for patients suffering from rare, life-threatening genetic diseases of the central nervous system.